Search

Omnicell Inc

Chiusa

SettoreSettore sanitario

36.18 0.67

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

35.76

Massimo

37.2

Metriche Chiave

By Trading Economics

Entrata

13M

24M

Vendite

2.3M

312M

P/E

Media del settore

44.482

57.371

EPS

0.7

Margine di Profitto

7.78

Dipendenti

3,485

EBITDA

-22M

14M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+52.65% upside

Dividendi

By Acuity

Utili prossimi

29 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-248M

1.6B

Apertura precedente

35.51

Chiusura precedente

36.18

Notizie sul Sentiment di mercato

By Acuity

3%

97%

2 / 340 Classifica in Healthcare

Omnicell Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 ago 2026, 22:51 UTC

Omnicell Inc shares are lower in after-market hours, reflecting broader negative sentiment amid rising sovereign bond yields and inflation concerns.

17 ago 2026, 23:36 UTC

Omnicell shares are higher in after-market trading, gaining after closing up on Monday. The broader market showed mixed performance amid rising crude oil prices.

14 ago 2026, 23:01 UTC

Omnicell Inc shares rose in after-market trading, recovering from an early low. The stock remains below its 20-day moving average.

12 ago 2026, 19:41 UTC

News

Omnicell shares are higher amid positive sentiment ahead of management's meetings with KeyBanc in Philadelphia and New York this month.

11 ago 2026, 22:16 UTC

Omnicell Inc shares are higher in after-market trading, with no specific news identified. Market focus remains on inflation data and Federal Reserve interest rate hikes.

10 ago 2026, 19:16 UTC

News

Omnicell Inc reported second-quarter revenue of $312.21 million and upgraded its guidance, contributing to shares trading higher since Friday's close.

7 ago 2026, 23:16 UTC

Omnicell Inc shares are rising in after-market trading, reflecting broader market dynamics following a disappointing jobs report that reduced interest rate hike expectations.

6 ago 2026, 23:21 UTC

Omnicell Inc's shares are higher in after-market trading, showing strength following Thursday's close amid broader market dynamics and upcoming economic data.

5 ago 2026, 22:02 UTC

Omnicell Inc shares are higher in after-market trading, continuing an earlier session advance. The stock remains below its 20-day moving average and one-month range.

4 ago 2026, 20:07 UTC

Omnicell Inc. shares are trading lower, reflecting ongoing weakness and remaining significantly below the 20-day moving average. The stock peaked earlier in the session.

3 ago 2026, 23:02 UTC

Omnicell Inc shares are lower in after-market trading, following a weak session and remaining below their 20-day moving average. No specific news was identified.

31 lug 2026, 22:01 UTC

Omnicell Inc. shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down and remaining below the 20-day moving average.

30 lug 2026, 23:21 UTC

Omnicell Inc. shares moved lower in after-market trading amid notable volatility and broader market dynamics, including mixed Asian market performance and geopolitical tensions.

29 lug 2026, 18:26 UTC

News

Omnicell Inc shares are higher as analysts maintain a positive outlook ahead of Thursday's Q2 earnings announcement, following a strong prior quarter with $309.9 million in revenue.

28 lug 2026, 20:51 UTC

Omnicell Inc shares are lower in after-market hours. The decline comes amid no specific news and follows three sessions of higher closes.

27 lug 2026, 19:46 UTC

Omnicell Inc shares are higher today, supported by falling crude oil prices and easing geopolitical tensions following U.S. diplomatic efforts with Iran.

24 lug 2026, 20:13 UTC

Omnicell Inc shares are lower in after-market hours. No specific company news was identified to explain the decline amid recent market volatility.

22 lug 2026, 18:46 UTC

News

Omnicell Inc is trading lower amid negative sentiment and concerns over financial performance. The stock's current price is $41.95.

21 lug 2026, 19:51 UTC

Omnicell Inc's shares are lower during Tuesday's session, reversing from a recent trend of higher daily closes. No specific news was identified for the decline.

20 lug 2026, 19:36 UTC

News

Omnicell Inc shares are lower amid a report suggesting the stock is one to avoid, citing modest revenue growth and declining earnings per share. Current valuation is $45.39.

Confronto tra pari

Modifica del prezzo

Omnicell Inc Previsione

Obiettivo di Prezzo

By TipRanks

52.65% in crescita

Previsioni per 12 mesi

Media 55 USD  52.65%

Alto 65 USD

Basso 45 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Omnicell Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

6 ratings

6

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

2 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat